Utah Medical Products Inc (NASDAQ:UTMD)
| 92.66 Delayed Data As of Aug 11 |  +1.61 / +1.76%Today’s Change | 80.10 Today|||52-Week Range 133.87 | -7.34% Year-to-Date |
Latest UTMD News | Press Releases
No recent news for Utah Medical Products Inc.
Today’s Trading
| Previous close | 91.70 |
| Today’s open | 91.79 |
| Day’s range | 91.77 - 93.31 |
| Volume | 2,266 |
| Average volume (3 months) | 9,550 |
| Market cap | $325.1M |
Data as of 3:57pm ET, 08/11/2022
Growth & Valuation
| Earnings growth (last year) | +37.36% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +16.30% |
| P/E ratio | 22.2 |
| Price/Sales | 7.46 |
| Price/Book | 3.04 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Bonesupport Holding ... | 0.00 | 0.00% |
| APENApollo Endosurgery I... | +0.13 | +2.02% |
| EDAPEdap Tms SA | -0.17 | -2.27% |
| MESOMesoblast Ltd | +0.01 | +0.30% |
Data as of 3:59pm ET, 08/11/2022
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $49.1M |
| Annual profit (last year) | $14.8M |
| Net profit margin | 30.15% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Midvale, Utah |
Forecasts
